Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frexalimab vs Tacrolimus in Adult Kidney Transplant Recipients
NCT07412470Phase 3Recruiting
- Sponsor
- Sanofi
- Start
- Mar 2026
- Primary completion
- Aug 2029
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 3 trial of frexalimab in kidney transplant rejection, sponsored by Sanofi. Started Mar 2026; status: recruiting.
02
Drugs
frexalimab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT07412470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07412470.